Company / FCF Margin
Regeneron Pharmaceuticals FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
28.4%
FY2025
5-year range
23.6% / 30.5%
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#17 of 134
Health Care
What the data says
Regeneron Pharmaceuticals's fcf margin of 28.4% is higher than 87% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 10 years, ranging from 20.0% in FY2016 to 78.4% in FY2017.
Based on SEC 10-K filings.
28.4% in FY2025 with a 5-year CAGR of -6.8%. Top quartile in the Health Care sector.
Declined from 29.5% to 28.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +4.9pp
- 5-Year Change
- -6.8pp
- 10-Year Change
- -
Sector benchmark
Top 13% in Health CareTop 13% of 134This company 28.4% Sector average -637.8%
▼
+104.5% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 10.3% year-over-year.
- Currently 666.2pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 28.4% | +10.3% |
| FY2024 | 25.8% | -12.7% |
| FY2023 | 29.5% | +25.3% |
| FY2022 | 23.6% | -22.7% |
| FY2021 | 30.5% | -13.3% |
| FY2020 | 35.2% | +15.4% |
| FY2019 | 30.5% | -13.3% |
| FY2018 | 35.2% | -55.1% |
| FY2017 | 78.4% | +291.4% |
| FY2016 | 20.0% | +26.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026